top of page
< Back

How to Enroll in a Retatrutide (GLP-3) Clinical Trial

FAQ-000089

Direct Answer

The only current, legal way to access retatrutide is through enrollment in an active clinical trial. Eli Lilly's ongoing TRIUMPH and related trials are listed publicly on ClinicalTrials.gov, the official U.S. government registry of clinical studies, where you can search by condition, location, and eligibility criteria.

What Trial Enrollment Actually Involves

Legitimate trial participation includes a formal informed consent process, defined eligibility criteria you'll be screened against, real safety monitoring throughout the study, and no patient-paid cost for the medication itself, since trial participants don't purchase the drug, they receive it as part of the study.

How to Actually Search

On ClinicalTrials.gov, search for "retatrutide" directly, or search by the medication's development code, LY3437943, to find current listings. Filter by your location and check each listing's specific eligibility criteria carefully, trials often have real, specific requirements around BMI, existing health conditions, and prior treatment history.

Why This Is the Only Legitimate Path Right Now

Since retatrutide isn't FDA-approved, there's no prescription pathway and no legal compounding option, covered in more detail on our grey-market safety warning. Clinical trial enrollment is genuinely the only route that includes real medical oversight and a documented safety framework.

Bottom Line

If you're specifically interested in trying retatrutide before approval, clinical trial enrollment through ClinicalTrials.gov is the real, legitimate path, not a grey-market purchase, and it comes with genuine oversight and no direct medication cost.

References

  • ClinicalTrials.gov: Official U.S. Clinical Trial Registry

Related Resources

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Track retatrutide alongside every other GLP-1 medication on DietApp.com.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This article is for general informational purposes and is not medical advice.

how-to-enroll-retatrutide-glp-3-clinical-trial

bottom of page